Cabot (CBT) Competitors

$82.99 -1.54 (-1.82%)

Closing price 05/13/2026 03:59 PM Eastern

Extended Trading

$82.93 -0.06 (-0.07%)

As of 05/13/2026 04:10 PM Eastern

CBT vs. IOSP, ASIX, AVNT, CC, and FUL

Should you buy Cabot stock or one of its competitors? MarketBeat compares Cabot with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cabot include Innospec (IOSP), AdvanSix (ASIX), Avient (AVNT), Chemours (CC), and H. B. Fuller (FUL). These companies are all part of the "basic materials" sector.

How does Cabot compare to Innospec?

Cabot (NYSE:CBT) and Innospec (NASDAQ:IOSP) are both basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

In the previous week, Innospec had 9 more articles in the media than Cabot. MarketBeat recorded 19 mentions for Innospec and 10 mentions for Cabot. Innospec's average media sentiment score of 0.73 beat Cabot's score of 0.71 indicating that Innospec is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cabot	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Innospec	4 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Cabot has a beta of 0.78, indicating that its share price is 22% less volatile than the broader market. Comparatively, Innospec has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market.

Cabot presently has a consensus price target of $80.25, suggesting a potential downside of 3.30%. Given Cabot's stronger consensus rating and higher possible upside, equities research analysts clearly believe Cabot is more favorable than Innospec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cabot	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Innospec	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Cabot has higher revenue and earnings than Innospec. Cabot is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cabot	$3.71B	1.15	$331M	$5.29	15.69
Innospec	$1.78B	1.10	$116.60M	$4.59	17.36

Cabot has a net margin of 7.97% compared to Innospec's net margin of 6.38%. Cabot's return on equity of 21.33% beat Innospec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cabot	7.97%	21.33%	9.48%
Innospec	6.38%	9.32%	6.79%

Cabot pays an annual dividend of $1.80 per share and has a dividend yield of 2.2%. Innospec pays an annual dividend of $1.74 per share and has a dividend yield of 2.2%. Cabot pays out 34.0% of its earnings in the form of a dividend. Innospec pays out 37.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has increased its dividend for 14 consecutive years and Innospec has increased its dividend for 11 consecutive years.

93.2% of Cabot shares are owned by institutional investors. Comparatively, 96.6% of Innospec shares are owned by institutional investors. 3.1% of Cabot shares are owned by company insiders. Comparatively, 1.5% of Innospec shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Cabot beats Innospec on 13 of the 19 factors compared between the two stocks.

How does Cabot compare to AdvanSix?

AdvanSix (NYSE:ASIX) and Cabot (NYSE:CBT) are both basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability.

In the previous week, AdvanSix had 7 more articles in the media than Cabot. MarketBeat recorded 17 mentions for AdvanSix and 10 mentions for Cabot. Cabot's average media sentiment score of 0.71 beat AdvanSix's score of 0.12 indicating that Cabot is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AdvanSix	2 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cabot	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cabot has higher revenue and earnings than AdvanSix. Cabot is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdvanSix	$1.52B	0.40	$49.29M	$0.37	60.50
Cabot	$3.71B	1.15	$331M	$5.29	15.69

AdvanSix has a beta of 1.33, meaning that its stock price is 33% more volatile than the broader market. Comparatively, Cabot has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market.

86.4% of AdvanSix shares are held by institutional investors. Comparatively, 93.2% of Cabot shares are held by institutional investors. 5.0% of AdvanSix shares are held by company insiders. Comparatively, 3.1% of Cabot shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Cabot has a net margin of 7.97% compared to AdvanSix's net margin of 0.67%. Cabot's return on equity of 21.33% beat AdvanSix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdvanSix	0.67%	2.18%	1.05%
Cabot	7.97%	21.33%	9.48%

AdvanSix currently has a consensus price target of $25.67, suggesting a potential upside of 14.67%. Cabot has a consensus price target of $80.25, suggesting a potential downside of 3.30%. Given AdvanSix's stronger consensus rating and higher possible upside, analysts plainly believe AdvanSix is more favorable than Cabot.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdvanSix	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
Cabot	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 2.9%. Cabot pays an annual dividend of $1.80 per share and has a dividend yield of 2.2%. AdvanSix pays out 173.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cabot pays out 34.0% of its earnings in the form of a dividend. AdvanSix has raised its dividend for 2 consecutive years and Cabot has raised its dividend for 14 consecutive years.

Summary

Cabot beats AdvanSix on 11 of the 18 factors compared between the two stocks.

How does Cabot compare to Avient?

Avient (NYSE:AVNT) and Cabot (NYSE:CBT) are both mid-cap basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, media sentiment, analyst recommendations, valuation, risk and institutional ownership.

Avient presently has a consensus price target of $46.40, indicating a potential upside of 35.30%. Cabot has a consensus price target of $80.25, indicating a potential downside of 3.30%. Given Avient's stronger consensus rating and higher probable upside, analysts plainly believe Avient is more favorable than Cabot.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avient	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Cabot	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Avient had 6 more articles in the media than Cabot. MarketBeat recorded 16 mentions for Avient and 10 mentions for Cabot. Cabot's average media sentiment score of 0.71 beat Avient's score of 0.54 indicating that Cabot is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avient	4 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Cabot	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Avient has a beta of 1.31, suggesting that its share price is 31% more volatile than the broader market. Comparatively, Cabot has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market.

Cabot has higher revenue and earnings than Avient. Cabot is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avient	$3.26B	0.96	$81.90M	$1.72	19.94
Cabot	$3.71B	1.15	$331M	$5.29	15.69

Avient pays an annual dividend of $1.10 per share and has a dividend yield of 3.2%. Cabot pays an annual dividend of $1.80 per share and has a dividend yield of 2.2%. Avient pays out 64.0% of its earnings in the form of a dividend. Cabot pays out 34.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Avient has increased its dividend for 1 consecutive years and Cabot has increased its dividend for 14 consecutive years.

Cabot has a net margin of 7.97% compared to Avient's net margin of 4.81%. Cabot's return on equity of 21.33% beat Avient's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avient	4.81%	11.11%	4.40%
Cabot	7.97%	21.33%	9.48%

95.5% of Avient shares are held by institutional investors. Comparatively, 93.2% of Cabot shares are held by institutional investors. 0.9% of Avient shares are held by company insiders. Comparatively, 3.1% of Cabot shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Cabot beats Avient on 11 of the 19 factors compared between the two stocks.

How does Cabot compare to Chemours?

Chemours (NYSE:CC) and Cabot (NYSE:CBT) are both mid-cap basic materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership.

Cabot has lower revenue, but higher earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemours	$5.82B	0.65	-$386M	-$2.64	N/A
Cabot	$3.71B	1.15	$331M	$5.29	15.69

In the previous week, Chemours had 1 more articles in the media than Cabot. MarketBeat recorded 11 mentions for Chemours and 10 mentions for Cabot. Cabot's average media sentiment score of 0.71 beat Chemours' score of 0.34 indicating that Cabot is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemours	4 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cabot	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Chemours presently has a consensus price target of $23.09, indicating a potential downside of 8.54%. Cabot has a consensus price target of $80.25, indicating a potential downside of 3.30%. Given Cabot's higher possible upside, analysts clearly believe Cabot is more favorable than Chemours.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemours	1 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38
Cabot	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Chemours has a beta of 1.47, suggesting that its share price is 47% more volatile than the broader market. Comparatively, Cabot has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market.

76.3% of Chemours shares are owned by institutional investors. Comparatively, 93.2% of Cabot shares are owned by institutional investors. 0.9% of Chemours shares are owned by company insiders. Comparatively, 3.1% of Cabot shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 1.4%. Cabot pays an annual dividend of $1.80 per share and has a dividend yield of 2.2%. Chemours pays out -13.3% of its earnings in the form of a dividend. Cabot pays out 34.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has increased its dividend for 14 consecutive years. Cabot is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Cabot has a net margin of 7.97% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Cabot's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemours	-6.82%	52.49%	1.78%
Cabot	7.97%	21.33%	9.48%

Summary

Cabot beats Chemours on 12 of the 19 factors compared between the two stocks.

How does Cabot compare to H. B. Fuller?

Cabot (NYSE:CBT) and H. B. Fuller (NYSE:FUL) are both mid-cap basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, risk, institutional ownership and valuation.

Cabot has higher revenue and earnings than H. B. Fuller. Cabot is trading at a lower price-to-earnings ratio than H. B. Fuller, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cabot	$3.71B	1.15	$331M	$5.29	15.69
H. B. Fuller	$3.47B	0.93	$151.97M	$3.03	19.61

In the previous week, Cabot had 9 more articles in the media than H. B. Fuller. MarketBeat recorded 10 mentions for Cabot and 1 mentions for H. B. Fuller. H. B. Fuller's average media sentiment score of 1.03 beat Cabot's score of 0.71 indicating that H. B. Fuller is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cabot	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
H. B. Fuller	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cabot pays an annual dividend of $1.80 per share and has a dividend yield of 2.2%. H. B. Fuller pays an annual dividend of $0.98 per share and has a dividend yield of 1.6%. Cabot pays out 34.0% of its earnings in the form of a dividend. H. B. Fuller pays out 32.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has raised its dividend for 14 consecutive years and H. B. Fuller has raised its dividend for 57 consecutive years.

Cabot has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market. Comparatively, H. B. Fuller has a beta of 0.95, meaning that its stock price is 5% less volatile than the broader market.

Cabot currently has a consensus price target of $80.25, indicating a potential downside of 3.30%. H. B. Fuller has a consensus price target of $65.50, indicating a potential upside of 10.26%. Given H. B. Fuller's stronger consensus rating and higher possible upside, analysts plainly believe H. B. Fuller is more favorable than Cabot.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cabot	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
H. B. Fuller	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.57

93.2% of Cabot shares are owned by institutional investors. Comparatively, 95.9% of H. B. Fuller shares are owned by institutional investors. 3.1% of Cabot shares are owned by insiders. Comparatively, 1.8% of H. B. Fuller shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Cabot has a net margin of 7.97% compared to H. B. Fuller's net margin of 4.62%. Cabot's return on equity of 21.33% beat H. B. Fuller's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cabot	7.97%	21.33%	9.48%
H. B. Fuller	4.62%	11.84%	4.52%

Summary

Cabot and H. B. Fuller tied by winning 10 of the 20 factors compared between the two stocks.

Get Cabot News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CBT vs. The Competition

Export

Metric	Cabot	CHEM Industry	Materials Sector	NYSE Exchange
Market Cap	$4.36B	$14.01B	$5.01B	$22.95B
Dividend Yield	2.13%	2.22%	4.97%	4.06%
P/E Ratio	15.69	38.24	23.85	28.29
Price / Sales	1.15	2.03	7,382.91	24.50
Price / Cash	8.13	12.57	27.65	25.11
Price / Book	2.54	2.09	7.08	4.73
Net Income	$331M	$179.02M	$159.16M	$1.07B
7 Day Performance	2.11%	3.39%	2.64%	-1.11%
1 Month Performance	11.25%	5.72%	3.24%	1.36%
1 Year Performance	10.23%	39.98%	88.19%	24.41%

Cabot Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CBT Cabot	3.2623 of 5 stars	$82.99 -1.8%	$80.25 -3.3%	+8.6%	$4.36B	$3.71B	15.69	4,100	Analyst Forecast
IOSP Innospec	3.5288 of 5 stars	$76.48 -0.5%	N/A	-11.9%	$1.91B	$1.78B	16.34	2,450	Earnings Report Analyst Downgrade
ASIX AdvanSix	3.6436 of 5 stars	$25.43 +0.2%	$25.67 +0.9%	-6.5%	$683.95M	$1.52B	14.05	1,410	Earnings Report Dividend Announcement Analyst Upgrade
AVNT Avient	4.6052 of 5 stars	$35.56 -3.3%	$47.00 +32.2%	-11.6%	$3.37B	$3.26B	39.96	9,000	Earnings Report
CC Chemours	3.1773 of 5 stars	$27.22 -1.9%	$20.70 -23.9%	+114.1%	$4.16B	$5.81B	N/A	5,700	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CBT) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cabot (CBT) Competitors